VACCINEX, INC.
VCNX · OTC · SIC 2834: Pharmaceutical Preparations
Business Summary
1 Item 1A. Risk Factors 45 Item 1B. Unresolved Staff Comments 71 Item 1C. Cybersecurity 71 Item 2. Properties 72 Item 3. Legal Proceedings 72 Item 4. Mine Safety Disclosures 72 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 73 Item 6. Reserved 73 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 74 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 83 Item 8. F...
Next Earnings
Q2 FY2026 — expected 2026-09-18
Key Facts from Earnings Calls
| Type | Subject | Detail | Quarter |
|---|
| topic_mention | VCNX | discussed_in_filing Cybersecurity | |
| topic_mention | VCNX | discussed_in_filing Cybersecurity | |
| topic_mention | VCNX | discussed_in_filing Cybersecurity | |
| topic_mention | VCNX | discussed_in_filing Cybersecurity | |
Annual Reports (10-K)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2025-04-15 | 2024-12-31 | 0000950170-25-054318 | EDGAR | 90K words |
| 2024-04-02 | 2023-12-31 | 0000950170-24-039700 | EDGAR | — |
| 2023-03-31 | 2022-12-31 | 0000950170-23-011354 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0001564590-22-012778 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001564590-21-016874 | EDGAR | — |
| 2020-03-09 | 2019-12-31 | 0001564590-20-009251 | EDGAR | — |
| 2019-03-13 | 2018-12-31 | 0001564590-19-007458 | EDGAR | — |
Quarterly Reports (10-Q)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2024-11-14 | 2024-09-30 | 0000950170-24-127139 | EDGAR | 27K words |
| 2024-08-14 | 2024-06-30 | 0000950170-24-097217 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0000950170-24-060603 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0000950170-23-062454 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0000950170-23-042073 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0000950170-23-022252 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001564590-22-037499 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001564590-22-029397 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001564590-22-020252 | EDGAR | — |
| 2021-11-08 | 2021-09-30 | 0001564590-21-055065 | EDGAR | — |
| 2021-08-16 | 2021-06-30 | 0001564590-21-044453 | EDGAR | — |
| 2021-05-17 | 2021-03-31 | 0001564590-21-028189 | EDGAR | — |
Recent Current Reports (8-K)
| Filed | Accession | Source | Full Text |
|---|
| 2025-03-19 | 0001193125-25-057850 | EDGAR | 0K words |
| 2025-03-07 | 0001193125-25-049988 | EDGAR | — |
| 2024-12-17 | 0001193125-24-280155 | EDGAR | — |
| 2024-11-14 | 0001193125-24-258757 | EDGAR | — |
| 2024-10-09 | 0001193125-24-235251 | EDGAR | — |
| 2024-09-19 | 0001193125-24-221790 | EDGAR | — |
| 2024-09-13 | 0001193125-24-218870 | EDGAR | — |
| 2024-08-20 | 0001193125-24-203149 | EDGAR | — |
| 2024-08-14 | 0001193125-24-200272 | EDGAR | — |
| 2024-07-31 | 0001193125-24-189569 | EDGAR | — |
143 total filings indexed. 114 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers
Company Identity
| CIK | 0001205922 |
| Ticker | VCNX |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: 0dd9ad48aebce22152915fe89ad5c258954d67b6725625be9541f1a351436c35
parent: 28145a150d2657d6a5755c2744953915d9d72fda25882cf81eb1d5064bcd83ea
content hash: 7dc5783452b91010d81a9ef53d66d2f99d384681e9e0b8da7231cf2e9207efc8
signed: 2026-04-13T04:48:03.601Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf